The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to medical device company Zephyr Sleep Technologies’ latest update to MATRx plus.
The clearance eliminates the requirement for a nasal cannula during a sleep theranostic test and makes setting up the take-home Treatment Planning test simpler. Patients now only need a single fingertip pulse oximetry probe for the test.
All existing MATRx plus users who are Connected Program subscribers will receive the update at no additional charge.
